Company performance
Add to research
Current Price
as of May 12, 2025$24.62
P/E Ratio
N/A
Market Cap
$1.42B
Description
Add to research
Structure Therapeutics, Inc. is a clinical stage global biopharmaceutical company, which engages in developing novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its pipeline includes Aleniglipron GSBR-1290, ACCG-2671, GIPR, GCGR, ANPA-0073, and LTSE-2578. The company was founded by Raymond C. Stevens in February 2019 and is headquartered in South San Francisco, CA.
Metrics
Add to research
Overview
- HQSouth San Francisco, CA
- SectorHealth Technology
- IndustryBiotechnology
- TickerGPCR
- Price$24.62-3.72%
Trading Information
- Market cap$1.42B
- Float95.09%
- Average Daily Volume (1m)1,150,662
- Average Daily Volume (3m)973,798
- EPS-$2.58
Company
- RevenueN/A
- Rev growth (1yr)N/A
- Net income-$46.90M
- Gross marginN/A
- EBITDA marginN/A
- EBITDA-$55.70M
- EV$163.43M
- EV/RevenueN/A
- P/EN/A
- P/SN/A
- P/B1.72
- Debt/Equity0.92
Documents
Add to research
Factset Street Account